Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study – LANCET ONCOLOGY

Leal, T; Kotecha, R; Ramlau, R; Zhang, L; Milanowski, J; Cobo, M; Roubec, J; Petruzelka, L; Havel, L; Kalmadi, S; Ward, J; Andric, Z; Berghmans, T; Gerber, DE; Kloecker, G; Panikkar, R; Aerts, J; Delmonte, A; Pless, M; Greil, R; Rolfo, C; Akerley, W; Eaton, M; Iqbal,...

Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer With High Tumor Mutation Burden A Nonrandomized Controlled Trial – JAMA ONCOLOGY

Provencio, M; Ortega, AL; Coves-Sarto, J; Calvo, V; Marsé-Fabregat, R; Dómine, M; Guirado, M; Carcereny, E; Fernández, N; Alvarez, R; Blanco, R; León-Mateos, L; Sánchez-Torres, JM; Sullivan, IG; Cobo, M; Sánchez-Hernández, A; Massuti, B; Sierra-Rodero, B;...

One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study – BMJ SUPPORTIVE & PALLIATIVE CARE

Dols, MC; Zambrano, CB; Cabezón-Gutiérrez, L; Chicas-Sett, R; López-Barajas, MIB; Navalón, FJG; Pérez, JLF; Bermúdez, GS; Torres, PT; Mingorance, ID; Marín, AG; Oriol, AL; Lario, AP; Mauriño, PS; Gómez, OH; Muñoz, DM; González, IH; Sanz-Yagüe, A; López, BS –...

Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1-High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial – JOURNAL OF THORACIC ONCOLOGY

Cho, Byoung Chul; Lee, Jong Seok; Wu, Yi-Long; Cicin, Irfan; Dols, Manuel Cobo; Ahn, Myung-Ju; Cuppens, Kristof; Veillon, Remi; Nadal, Ernest; Dias, Josiane Mourao; Martin, Claudio; Reck, Martin; Garon, Edward B.; Felip, Enriqueta; Paz-Ares, Luis; Mornex, Francoise;...